The West Virginia Racing Commission (WVRC) Feb. 26 approved a resolution agreeing in principle with the effort to bring uniform medication, penalty, and testing rules to racing jurisdictions in the Mid-Atlantic and Northeast regions.

The Maryland Racing Commission was the first to do so Feb. 19. Other states that have met privately to discuss the plan include Delaware, Massachusetts, New Jersey, New York, Pennsylvania, and Virginia.

Key components of the plan floated by Thoroughbred Horsemen’s Association chairman Alan Foreman are threshold levels and withdrawal times for 24 therapeutic medications; improved, uniform drug testing; a ban on adjunct bleeder drugs; continued race-day use of furosemide, also known as Salix or Lasix; and administration of Salix by regulatory veterinarians. Foreman has said he hopes the Mid-Atlantic action serves as a template for the rest of the country.

WVRC deputy attorney general Kelli Talbott, who attended the first Mid-Atlantic meeting earlier in February at Delaware Park, said West Virginia when it rewrote its Thoroughbred racing rules already addressed some issues. She noted, however, West Virginia has threshold levels only for seven of the 24 therapeutic drugs

Create a free account with TheHorse.com to view this content.

TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.

Start your free account today!

Already have an account?
and continue reading.